Prot #CC-10004-PPSO-001: A Phase 2, Multicenter, Open-Label Study To Assess The Safety, Tolerability And Pharmacokinetics Of Apremilast (CC-10004) In Pediatric Subjects With Moderate To Severe Plaque Psoriasis

Project: Research project

Project Details

StatusFinished
Effective start/end date12/22/1512/22/18

Funding

  • INC Research, LLC (Prot #CC-10004-PPSO-001)
  • Celgene Corporation (Prot #CC-10004-PPSO-001)